文献速递神经肿瘤神经重症

脑肿瘤开颅术前血糖浓度与死亡率的相关性

Association of preoperative glucose concentration with mortality in patients undergoing craniotomy for brain tumor.
PubMed 文献 · J Neurosurg · 2022-10-28

该回顾性队列研究纳入2011年1月至2021年3月在四川大学华西医院因脑肿瘤行开颅切除术的12281例患者,评估术前血糖水平与30天死亡率的关系。结果显示,与血糖正常(<5.6 mmol/L)相比,轻度、中度和重度高血糖患者的30天死亡风险均升高,且呈趋势性(P<0.001)。

要点

  • 总体30天死亡率为2.0%(242/12281)。
  • 血糖正常、轻度、中度、重度高血糖的30天死亡率分别为1.5%、2.5%、3.8%、6.5%。
  • 血糖每升高1 mmol/L,30天死亡调整OR为1.13(95%CI 1.08-1.19)。

核心结论

  • 在脑肿瘤开颅患者中,即使轻度高血糖也与死亡率升高相关,其血糖水平远低于常用阈值。

研究设计与样本

  • 回顾性队列研究,纳入2011年1月至2021年3月在四川大学华西医院因脑肿瘤行开颅切除术的患者12281例。

主要发现

  • 总体30天死亡率为2.0%(242/12281);血糖正常(<5.6 mmol/L)组为1.5%,轻度高血糖(5.6-6.9 mmol/L)组为2.5%,中度高血糖(7.0-11.0 mmol/L)组为3.8%,重度高血糖(>11.0 mmol/L)组为6.5%。
  • 与血糖正常组相比,轻度高血糖组30天死亡调整OR为1.44(95%CI 1.05-2.00),中度高血糖组OR为2.04(95%CI 1.41-2.96),重度高血糖组OR为3.76(95%CI 1.96-7.20),趋势检验P<0.001。
  • 血糖作为连续变量时,每升高1 mmol/L,30天死亡的调整OR为1.13(95%CI 1.08-1.19)。
  • 将术前血糖水平加入预测模型后,预测死亡率的曲线下面积和分类净重分类指数均显著改善。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Hyperglycemia is associated with worse outcomes in ambulatory settings and specialized hospital settings, but there are sparse data on the importance of preoperative blood glucose measurement before brain tumor craniotomy. The authors sought to investigate the association between preoperative glucose level and 30-day mortality rate in patients undergoing brain tumor resection. METHODS: This retrospective cohort study included patients undergoing craniotomy for brain tumors at West China Hospital, Sichuan University, from January 2011 to March 2021. Surgical mortality rates were evaluated in patients who had normal glycemia (< 5.6 mmol/L) as well as mild (5.6-6.9 mmol/L), moderate (7.0-11.0 mmol/L), and severe hyperglycemia (> 11.0 mmol/L). RESULTS: The study included 12,281 patients who underwent tumor resection via craniotomy. The overall 30-day mortality rate was 2.0% (242/12,281), whereas the rates for normal glycemia and mild, moderate, and severe hyperglycemia were 1.5%, 2.5%, 3.8%, and 6.5%, respectively. Compared with normal glycemia, the odds of mortality at 30 days were higher in patients with mild hyperglycemia (adjusted odds ratio [OR] 1.44, 95% confidence interval [CI] 1.05-2.00), moderate hyperglycemia (OR 2.04, 95% CI 1.41-2.96), and severe hyperglycemia (OR 3.76, 95% CI 1.96-7.20; p < 0.001 for trend). When blood glucose was analyzed as a continuous variable, for each 1 mmol/L increase in blood glucose, the adjusted OR of 30-day mortality was 1.13 (95% CI 1.08-1.19). The addition of a preoperative glucose level significantly improved the area under the curve and categorical net reclassification index for prediction of mortality. CONCLUSIONS: In patients undergoing craniotomy for brain tumors, even mild hyperglycemia was associated with an increased mortality rate, at a glucose level that was much lower than the commonly applied level.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Tan H, Jia L, et al. Association of preoperative glucose concentration with mortality in patients undergoing craniotomy for brain tumor. J Neurosurg. 2022. PMID: 36308478. doi:10.3171/2022.9.JNS221251

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。